Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson’s disease, especially on bradykinesia
- 1 September 2017
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 160, 101-104
Abstract
No abstract availableKeywords
Funding Information
- Capital Characteristic Clinic Project of China (BJ-2012-147)
This publication has 24 references indexed in Scilit:
- Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance studyGut Pathogens, 2012
- Epidemiology and etiology of Parkinson’s disease: a review of the evidenceEuropean Journal of Epidemiology, 2011
- Differential Effect of Helicobacter pylori Eradication on Time‐Trends in Brady/Hypokinesia and Rigidity in Idiopathic ParkinsonismHelicobacter, 2010
- In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?Journal of Pharmacy and Pharmacology, 2009
- Helicobacter pylori infection and motor fluctuations in patients with Parkinson's diseaseMovement Disorders, 2008
- Cycad toxins, Helicobacter pylori and parkinsonism: Cholesterol glucosides as the common denomenatorMedical Hypotheses, 2006
- Role of Chronic Infection and Inflammation in the Gastrointestinal Tract in the Etiology and Pathogenesis of Idiopathic ParkinsonismHelicobacter, 2005
- Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestationsMovement Disorders, 2005
- THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMSProgress in Neurobiology, 1996
- Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.Gut, 1994